Mankind Pharma completes acquisition of Bharat Serums and Vaccines Ltd (BSV) in a ₹13,768 crore deal
Acquiring Company
Mankind Pharma
Acquired Company
Bharat Serums and Vaccines Limited
New DelhiNavi MumbaiBiotechnologyHealth CarePharmaceuticalPharmaceuticalDescription
Mankind Pharma has completed the transaction to acquire Bharat Serums and Vaccines Ltd (BSV) for a consideration of ₹13,768 crore. This strategic move positions Mankind Pharma as a market leader in the Indian women's health and fertility drug market, alongside access to other high entry barrier products in the critical care segment with established complex R&D tech platforms.
Quick answer
Mankind Pharma is acquiring Bharat Serums and Vaccines Limited for $0 million, announced October 24, 2024. Mankind Pharma is based in New Delhi, Delhi, India.
- How much did Mankind Pharma pay for Bharat Serums and Vaccines Limited?
- The reported deal value is $0 million.
- What does Mankind Pharma do?
- Mankind Pharma is a pharmaceutical company that has completed the transaction to acquire Bharat Serums and Vaccines Ltd (BSV), for a consideration of ₹13,768 crore.
- Where are Mankind Pharma and Bharat Serums and Vaccines Limited based?
- Mankind Pharma is based in New Delhi, Delhi, India. Bharat Serums and Vaccines Limited is based in Navi Mumbai, Maharashtra, India.
- Who are the decision-makers at Mankind Pharma?
- Fundz holds 5 contacts at Mankind Pharma. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Celltrion acquires iQone Healthcare Switzerland to strengthen European expansion (November 14, 2024)
- Lupin strengthens its presence in the South African market through the acquisition of nine leading brands (October 4, 2024)
- Scantox Group finalizes acquisition of Gentronix Ltd, a UK-based genetic toxicology Contract Research Organization ("CRO") (September 9, 2024)
- XOMA Royalty Corporation acquires Pulmokine Inc. for $20 Million to add Seralutinib, a Phase 3 Asset, to its Portfolio, $20M (December 2, 2024)
- Medtronic completes acquisition of Fortimedix to enhance its surgical technology portfolio (November 22, 2024)
- Novartis acquires Kate Therapeutics to strengthen gene therapy portfolio (November 21, 2024)
Who to call at Mankind Pharma, and when
When Mankind Pharma changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Mankind Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Mankind Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Mankind Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Mankind Pharma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Bharat Serums and Vaccines Limited?
Bharat Serums and Vaccines Limited was acquired by Mankind Pharma, based in New Delhi. The deal was reported on October 24, 2024. Mankind Pharma is a pharmaceutical company that has completed the transaction to acquire Bharat Serums and Vaccines Ltd (BSV), for a consideration of ₹13,768 crore. Mankind Pharma is privately held and operates in Biotechnology.
When did Mankind Pharma acquire Bharat Serums and Vaccines Limited?
Mankind Pharma's acquisition of Bharat Serums and Vaccines Limited was reported on October 24, 2024. Mankind Pharma has completed the transaction to acquire Bharat Serums and Vaccines Ltd (BSV) for a consideration of ₹13,768 crore. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Bharat Serums and Vaccines Limited do?
Bharat Serums and Vaccines Limited (BSV) is a wholly owned subsidiary specializing in vaccines and biopharmaceuticals. The company works towards the development and manufacture of a range of healthcare products. It is privately held, operating in Pharmaceutical, and is based in Navi Mumbai.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.